CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN
Investment to Accelerate Development of Next Gen Cancer Therapies with the Mission to Transform Patient Care
News provided by
Share this article
Share this article
TAMPA, Fla. and NEW YORK, March 17, 2021 /PRNewswire/ M2GEN today announced a significant new investment by Clayton, Dubilier & Rice ( CD&R ) funds, the Merck Global Health Innovation Fund ( Merck GHI ), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care, in partnership with its existing shareholders. The financial terms of the transaction, which closed today, were not disclosed.
CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.